Cargando…

Conformational cycle of human polyamine transporter ATP13A2

Dysregulation of polyamine homeostasis strongly associates with human diseases. ATP13A2, which is mutated in juvenile-onset Parkinson’s disease and autosomal recessive spastic paraplegia 78, is a transporter with a critical role in balancing the polyamine concentration between the lysosome and the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Jianqiang, Xue, Chenyang, Fu, Lei, Yu, Zongjun, Nie, Minhan, Wu, Mengqi, Chen, Xinmeng, Liu, Kun, Bu, Ruiqian, Huang, Ying, Yang, Baisheng, Han, Jianming, Jiang, Qianru, Chan, Kevin C., Zhou, Ruhong, Li, Huilin, Huang, Ancheng, Wang, Yong, Liu, Zhongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082790/
https://www.ncbi.nlm.nih.gov/pubmed/37031211
http://dx.doi.org/10.1038/s41467-023-37741-0
Descripción
Sumario:Dysregulation of polyamine homeostasis strongly associates with human diseases. ATP13A2, which is mutated in juvenile-onset Parkinson’s disease and autosomal recessive spastic paraplegia 78, is a transporter with a critical role in balancing the polyamine concentration between the lysosome and the cytosol. Here, to better understand human ATP13A2-mediated polyamine transport, we use single-particle cryo-electron microscopy to solve high-resolution structures of human ATP13A2 in six intermediate states, including the putative E2 structure for the P5 subfamily of the P-type ATPases. These structures comprise a nearly complete conformational cycle spanning the polyamine transport process and capture multiple substrate binding sites distributed along the transmembrane regions, suggesting a potential polyamine transport pathway. Integration of high-resolution structures, biochemical assays, and molecular dynamics simulations allows us to obtain a better understanding of the structural basis of how hATP13A2 transports polyamines, providing a mechanistic framework for ATP13A2-related diseases.